Please use this identifier to cite or link to this item:
Title: A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia
Authors: Kurova, Nataliia 
Timofeeva, Elena V
Guiso, Nicole
Macina, Denis
Keywords: Pertussis;Seroprevalence;Vaccines;Waning
Issue Date: 18-Dec-2018
Publisher: Elsevier
Project: New trends in laboratory diagnosis of vaccine-preventable diseases of the respiratory tract / Новые направления в лабораторной диагностике вакциноуправляемых инфекций респираторного тракта. 
Journal: Vaccine 
Abstract: In Russia as in other countries introduction of infant vaccination against pertussis in 1950s led to dramatic decrease of whooping cough. The current vaccination schedule includes a 3-dose infant series and toddler booster; the pre-school booster was cancelled in 1980s and never reintroduced. Whole-cell vaccines, and in a smaller proportion acellular vaccines are used for all doses. However, pertussis incidence in urban settings is high with highest burden in school children. We conducted a study of seroprevalence of recent pertussis infection to estimate the duration of protection from the 4-dose series.
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2018.11.007
Appears in Collections:Journal articles

Files in This Item:
File Description SizeFormat 
1-s2.0-S0264410X18315160-main.pdf1.13 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 20, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.